AGOMÉLATINE HCS 25 mg, film-coated tablet 28 tablets
Active ingredients: Agomelatine, CO-CRISTAL D'AGOMÉLATINE-ACIDE CITRIQUE
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet28 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- AGOMÉLATINE HCS 25 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) OPA : polyamide orienté aluminium PVC-Aluminium de 28 comprimé(s)
- Marketing authorisation holder
- HCS (BELGIQUE)
- Reimbursement according to BDPM
- 15%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Mar 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60486279CIP73015558CIP133400930155585Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CO-CRISTAL D'AGOMÉLATINE-ACIDE CITRIQUEcomprimé | — | SA |
| AGOMÉLATINEcomprimé | 25,0 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.